Brain Neoplasms  >>  Conmana (icotinib) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Conmana (icotinib) / Betta Pharma
NCT02726568: High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases

Recruiting
2
30
RoW
Icotinib, SRS
Betta Pharmaceuticals Co., Ltd.
Non-small Cell Lung Cancer, Brain Metastases
12/21
12/22

Download Options